Number of the records: 1
HPMA-based polymeric conjugate of doxorubicin acting in concert with the host anti-tumour immunity
- 1.
SYSNO ASEP 0099646 Document Type C - Proceedings Paper (int. conf.) R&D Document Type Conference Paper Title HPMA-based polymeric conjugate of doxorubicin acting in concert with the host anti-tumour immunity Title Polymerní konjugát doxorubicinu na bázi HPMA, působící ve shodě s protinádorovou imunitou nositele Author(s) Šírová, Milada (MBU-M) RID, ORCID
Rossmann, Pavel (MBU-M)
Mrkvan, Tomáš (MBU-M)
Strohalm, Jiří (UMCH-V)
Šubr, Vladimír (UMCH-V) RID, ORCID
Plocová, Daniela (UMCH-V)
Ulbrich, Karel (UMCH-V) RID
Říhová, Blanka (MBU-M) RIDSource Title International Workshop on Drug Delivery Systems /5./. - Praha : Springer, 2007 Pages s. 26-26 Number of pages 1 s. Action International Workshop on Drug Delivery Systems /5./ Event date 15.05.2007-18.5.2007 VEvent location Třeštˇ Country CZ - Czech Republic Event type WRD Language eng - English Country CZ - Czech Republic Keywords doxorubicin Subject RIV EC - Immunology R&D Projects 1M0505 GA MŠMT - Ministry of Education, Youth and Sports (MEYS) CEZ AV0Z50200510 - MBU-M (2005-2011) AV0Z40500505 - UMCH-V (2005-2011) Annotation Polymeric conjugate Dox-HPMA-HuIg directly targets the tumour due to the EPR effect, it is not detrimental towards the immune system of the host, and acts in concert with the anti-tumour immune responses Workplace Institute of Microbiology Contact Eliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231 Year of Publishing 2008
Number of the records: 1